ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) Fundamental Analysis & Valuation

NASDAQ:ZBRA • US9892071054

Current stock price

234.28 USD
+1.24 (+0.53%)
Last:

This ZBRA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ZBRA Profitability Analysis

1.1 Basic Checks

  • ZBRA had positive earnings in the past year.
  • In the past year ZBRA had a positive cash flow from operations.
  • Each year in the past 5 years ZBRA has been profitable.
  • ZBRA had a positive operating cash flow in 4 of the past 5 years.
ZBRA Yearly Net Income VS EBIT VS OCF VS FCFZBRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • The Return On Assets of ZBRA (4.93%) is better than 71.77% of its industry peers.
  • The Return On Equity of ZBRA (11.68%) is better than 76.61% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 9.50%, ZBRA belongs to the top of the industry, outperforming 82.26% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for ZBRA is in line with the industry average of 8.10%.
  • The 3 year average ROIC (9.08%) for ZBRA is below the current ROIC(9.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.93%
ROE 11.68%
ROIC 9.5%
ROA(3y)5.2%
ROA(5y)7.04%
ROE(3y)12.05%
ROE(5y)16.23%
ROIC(3y)9.08%
ROIC(5y)11.91%
ZBRA Yearly ROA, ROE, ROICZBRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • Looking at the Profit Margin, with a value of 7.77%, ZBRA is in the better half of the industry, outperforming 75.81% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ZBRA has declined.
  • With an excellent Operating Margin value of 14.83%, ZBRA belongs to the best of the industry, outperforming 86.29% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ZBRA has remained more or less at the same level.
  • ZBRA has a Gross Margin of 48.05%. This is amongst the best in the industry. ZBRA outperforms 82.26% of its industry peers.
  • ZBRA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.83%
PM (TTM) 7.77%
GM 48.05%
OM growth 3Y-2.89%
OM growth 5Y-0.76%
PM growth 3Y-1.03%
PM growth 5Y-7.28%
GM growth 3Y1.92%
GM growth 5Y1.31%
ZBRA Yearly Profit, Operating, Gross MarginsZBRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ZBRA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ZBRA is still creating some value.
  • The number of shares outstanding for ZBRA has been reduced compared to 1 year ago.
  • Compared to 5 years ago, ZBRA has less shares outstanding
  • Compared to 1 year ago, ZBRA has a worse debt to assets ratio.
ZBRA Yearly Shares OutstandingZBRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
ZBRA Yearly Total Debt VS Total AssetsZBRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • ZBRA has an Altman-Z score of 3.18. This indicates that ZBRA is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of ZBRA (3.18) is comparable to the rest of the industry.
  • The Debt to FCF ratio of ZBRA is 3.01, which is a good value as it means it would take ZBRA, 3.01 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.01, ZBRA is in the better half of the industry, outperforming 73.39% of the companies in the same industry.
  • A Debt/Equity ratio of 0.66 indicates that ZBRA is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ZBRA (0.66) is worse than 80.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 3.01
Altman-Z 3.18
ROIC/WACC1
WACC9.48%
ZBRA Yearly LT Debt VS Equity VS FCFZBRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • ZBRA has a Current Ratio of 0.97. This is a bad value and indicates that ZBRA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ZBRA's Current ratio of 0.97 is on the low side compared to the rest of the industry. ZBRA is outperformed by 92.74% of its industry peers.
  • ZBRA has a Quick Ratio of 0.97. This is a bad value and indicates that ZBRA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.58, ZBRA is doing worse than 93.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.58
ZBRA Yearly Current Assets VS Current LiabilitesZBRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ZBRA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 17.25% over the past year.
  • The Earnings Per Share has been growing slightly by 4.34% on average over the past years.
  • ZBRA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.33%.
  • Measured over the past years, ZBRA shows a small growth in Revenue. The Revenue has been growing by 3.94% on average per year.
EPS 1Y (TTM)17.25%
EPS 3Y-3.25%
EPS 5Y4.34%
EPS Q2Q%8.25%
Revenue 1Y (TTM)8.33%
Revenue growth 3Y-2.27%
Revenue growth 5Y3.94%
Sales Q2Q%9.22%

3.2 Future

  • ZBRA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.22% yearly.
  • Based on estimates for the next years, ZBRA will show a small growth in Revenue. The Revenue will grow by 7.44% on average per year.
EPS Next Y14.53%
EPS Next 2Y13.53%
EPS Next 3Y12.86%
EPS Next 5Y15.22%
Revenue Next Year11.38%
Revenue Next 2Y8.36%
Revenue Next 3Y7.6%
Revenue Next 5Y7.44%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ZBRA Yearly Revenue VS EstimatesZBRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
ZBRA Yearly EPS VS EstimatesZBRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

7

4. ZBRA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.79, which indicates a correct valuation of ZBRA.
  • 88.71% of the companies in the same industry are more expensive than ZBRA, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of ZBRA to the average of the S&P500 Index (27.53), we can say ZBRA is valued slightly cheaper.
  • With a Price/Forward Earnings ratio of 12.91, ZBRA is valued correctly.
  • ZBRA's Price/Forward Earnings ratio is rather cheap when compared to the industry. ZBRA is cheaper than 87.10% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 37.95. ZBRA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 14.79
Fwd PE 12.91
ZBRA Price Earnings VS Forward Price EarningsZBRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ZBRA indicates a somewhat cheap valuation: ZBRA is cheaper than 77.42% of the companies listed in the same industry.
  • ZBRA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ZBRA is cheaper than 89.52% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.63
EV/EBITDA 13.85
ZBRA Per share dataZBRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ZBRA has a very decent profitability rating, which may justify a higher PE ratio.
  • ZBRA's earnings are expected to grow with 12.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.02
PEG (5Y)3.41
EPS Next 2Y13.53%
EPS Next 3Y12.86%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ZBRA Dividend Analysis

5.1 Amount

  • ZBRA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ZBRA Fundamentals: All Metrics, Ratios and Statistics

ZEBRA TECHNOLOGIES CORP-CL A

NASDAQ:ZBRA (4/17/2026, 3:22:07 PM)

234.28

+1.24 (+0.53%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-12
Earnings (Next)05-12
Inst Owners98.48%
Inst Owner Change-0.01%
Ins Owners0.85%
Ins Owner Change5.79%
Market Cap11.33B
Revenue(TTM)5.40B
Net Income(TTM)419.00M
Analysts79.23
Price Target339.16 (44.77%)
Short Float %4.5%
Short Ratio2.65
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.28%
Min EPS beat(2)-1.97%
Max EPS beat(2)1.41%
EPS beat(4)3
Avg EPS beat(4)3.72%
Min EPS beat(4)-1.97%
Max EPS beat(4)8.97%
EPS beat(8)6
Avg EPS beat(8)5.62%
EPS beat(12)8
Avg EPS beat(12)3.99%
EPS beat(16)11
Avg EPS beat(16)2.96%
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-2.08%
Max Revenue beat(2)-1.49%
Revenue beat(4)0
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-2.08%
Max Revenue beat(4)-0.61%
Revenue beat(8)3
Avg Revenue beat(8)-0.47%
Revenue beat(12)4
Avg Revenue beat(12)-1.17%
Revenue beat(16)6
Avg Revenue beat(16)-1.21%
PT rev (1m)-1.37%
PT rev (3m)-6.62%
EPS NQ rev (1m)0.1%
EPS NQ rev (3m)3.2%
EPS NY rev (1m)0%
EPS NY rev (3m)1.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.58%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)1.26%
Valuation
Industry RankSector Rank
PE 14.79
Fwd PE 12.91
P/S 2.1
P/FCF 13.63
P/OCF 12.36
P/B 3.16
P/tB N/A
EV/EBITDA 13.85
EPS(TTM)15.84
EY6.76%
EPS(NY)18.14
Fwd EY7.74%
FCF(TTM)17.18
FCFY7.33%
OCF(TTM)18.96
OCFY8.09%
SpS111.58
BVpS74.19
TBVpS-40.28
PEG (NY)1.02
PEG (5Y)3.41
Graham Number162.612 (-30.59%)
Profitability
Industry RankSector Rank
ROA 4.93%
ROE 11.68%
ROCE 12.03%
ROIC 9.5%
ROICexc 9.68%
ROICexgc 63.89%
OM 14.83%
PM (TTM) 7.77%
GM 48.05%
FCFM 15.4%
ROA(3y)5.2%
ROA(5y)7.04%
ROE(3y)12.05%
ROE(5y)16.23%
ROIC(3y)9.08%
ROIC(5y)11.91%
ROICexc(3y)9.75%
ROICexc(5y)12.66%
ROICexgc(3y)53.88%
ROICexgc(5y)104.36%
ROCE(3y)11.5%
ROCE(5y)15.08%
ROICexgc growth 3Y-21.35%
ROICexgc growth 5YN/A
ROICexc growth 3Y-12.63%
ROICexc growth 5Y-9.69%
OM growth 3Y-2.89%
OM growth 5Y-0.76%
PM growth 3Y-1.03%
PM growth 5Y-7.28%
GM growth 3Y1.92%
GM growth 5Y1.31%
F-Score5
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 3.01
Debt/EBITDA 2.4
Cap/Depr 46.49%
Cap/Sales 1.59%
Interest Coverage 6.2
Cash Conversion 93.1%
Profit Quality 198.33%
Current Ratio 0.97
Quick Ratio 0.58
Altman-Z 3.18
F-Score5
WACC9.48%
ROIC/WACC1
Cap/Depr(3y)43.41%
Cap/Depr(5y)39.71%
Cap/Sales(3y)1.56%
Cap/Sales(5y)1.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.25%
EPS 3Y-3.25%
EPS 5Y4.34%
EPS Q2Q%8.25%
EPS Next Y14.53%
EPS Next 2Y13.53%
EPS Next 3Y12.86%
EPS Next 5Y15.22%
Revenue 1Y (TTM)8.33%
Revenue growth 3Y-2.27%
Revenue growth 5Y3.94%
Sales Q2Q%9.22%
Revenue Next Year11.38%
Revenue Next 2Y8.36%
Revenue Next 3Y7.6%
Revenue Next 5Y7.44%
EBIT growth 1Y4.58%
EBIT growth 3Y-5.1%
EBIT growth 5Y3.15%
EBIT Next Year26.84%
EBIT Next 3Y13.89%
EBIT Next 5Y11.74%
FCF growth 1Y-12.89%
FCF growth 3Y26.25%
FCF growth 5Y-1.47%
OCF growth 1Y-9.48%
OCF growth 3Y23.4%
OCF growth 5Y-0.95%

ZEBRA TECHNOLOGIES CORP-CL A / ZBRA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ZEBRA TECHNOLOGIES CORP-CL A?

ChartMill assigns a fundamental rating of 5 / 10 to ZBRA.


Can you provide the valuation status for ZEBRA TECHNOLOGIES CORP-CL A?

ChartMill assigns a valuation rating of 7 / 10 to ZEBRA TECHNOLOGIES CORP-CL A (ZBRA). This can be considered as Undervalued.


Can you provide the profitability details for ZEBRA TECHNOLOGIES CORP-CL A?

ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) has a profitability rating of 7 / 10.


How financially healthy is ZEBRA TECHNOLOGIES CORP-CL A?

The financial health rating of ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) is 4 / 10.